M&A Deal Summary |
|
|---|---|
| Date | 2025-07-29 |
| Target | Durect |
| Sector | Life Science |
| Buyer(s) | Bausch Health |
| Deal Type | Add-on Acquisition |
| Deal Value | 63M USD |
| Advisor(s) | Locust Walk Partners (Financial) Orrick (Legal) |
SEARCH BY
| Category | Company |
|---|---|
| Sector | Life Science |
| Employees | 20,270 |
| Revenue | 9.6B USD (2024) |
Bausch Health is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics. Bausch Health is based in Laval, Quebec.
| DEAL STATS | # |
|---|---|
| Overall | 36 of 36 |
| Sector: Life Science M&A | 22 of 22 |
| Type: Add-on Acquisition M&A Deals | 26 of 26 |
| State: California M&A | 7 of 7 |
| Country: United States M&A | 23 of 23 |
| Year: 2025 M&A | 1 of 1 |
| Size (of disclosed) | 22 of 28 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-03-31 |
Amoun Pharmaceutical Company
Cairo, Egypt Amoun Pharmaceutical Company is a developer, manufacturer, marketer, distributer, and export of a wide range of human pharmaceutical and animal health products. Amoun Pharmaceutical Company is based in Cairo, Egypt. |
Sell | $740M |